Moramide intermediate
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
3-Methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid
|
|
Clinical data | |
Routes of administration |
N/A |
Legal status |
|
Identifiers | |
CAS Number | 3626-55-9 |
ATC code | None |
PubChem | CID 567581 |
ChemSpider | 493453 |
Synonyms | moramide intermediate |
Chemical data | |
Formula | C21H25NO3 |
Molar mass | 339.4281 g/mol |
|
|
|
Moramide intermediate (3-methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.
In the United States, moramide intermediate is designated as a Schedule II controlled substance[1], and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil. [2]
See also[edit]
- Moramide
- Methadone intermediate
- Pethidine intermediate A
- Pethidine intermediate B (norpethidine)
- Pethidine intermediate C (pethidinic acid)
References[edit]
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |